10:24 ET -- CVS is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The healthcare giant reported third-quarter revenue of $89.76 billion and earnings of $1.75 a share, surpassing the expectations of analysts polled by FactSet. However, CVS dropped its guidance range for 2023 EPS to $6.37 to $6.61 a share, citing headwinds in key business segments. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)

 

(END) Dow Jones Newswires

November 01, 2023 10:39 ET (14:39 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more CVS Health Charts.